Skip to main content
. 2013 May 2;22(19):2655–2664. doi: 10.1089/scd.2012.0703

FIG. 4.

FIG. 4.

Number of tumor spheres (A) and overall percentage of tumor spheres (B) in antibody-enriched and antibody-depleted fractions of HCC cell lines (HuH7, PLC/PRF/5, and SNU182 cells). *Indicates significantly greater number of tumour spheres in antibody enriched compared to antibody depleted fractions. Significant differences were determined by a two sample t-test (p<0.05).